Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level

被引:34
作者
Magrangeas, F
Cormier, ML
Descamps, G
Gouy, N
Lodé, L
Mellerin, MP
Harousseau, JL
Bataille, R
Minvielle, S
Avet-Loiseau, H
机构
[1] Univ Hosp, Inst Biol, Hematol Lab, F-44093 Nantes 1, France
[2] Univ Hosp, Dept Clin Hematol, F-44093 Nantes 1, France
关键词
D O I
10.1182/blood-2003-07-2501
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Although most multiple myeloma (MM) cases are characterized by the detection of a monoclonal immunoglobulin in the serum, about 15% of the patients present only immunoglobulin light chains, detected either in the urine or serum or both. These patients are designated as having light-chain (LC) MM. Using fiber-fluorescent in situ hybridization, and in contrast to patients and myeloma cell lines secreting heavy chains (who presented a legitimate functional IgH rearrangement in every case), LC MM never displayed a functional IgH recombination. Interestingly, most LC MM cases presented one IgH allele with a germline configuration (including the DJ region), the second allele being usually involved in an illegitimate recombination. Of note, most of these translocations occurred close to (or at) switch regions, even though in some cases, breakpoints involving nonswitch regions were observed. Thus, this study clearly showed that LC MM is due to the absence of legitimate IgH rearrangement at the DNA level, reflecting possible abnormalities in the IgH gene recombinations during B-cell maturation. Furthermore, it showed that this defect did not prevent the activation of the switch process because most of 14q32 translocations observed in LC MM occurred at switch regions. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:3869 / 3875
页数:7
相关论文
共 26 条
[1]
Avet-Loiseau H, 1999, CANCER RES, V59, P4546
[2]
Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants [J].
Avet-Loiseau, H ;
Garand, R ;
Lodé, L ;
Harousseau, JL ;
Bataille, R .
BLOOD, 2003, 101 (04) :1570-1571
[3]
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation [J].
Avet-Loiseau, H ;
Facon, T ;
Grosbois, B ;
Magrangeas, F ;
Rapp, MJ ;
Harousseau, JL ;
Minvielle, S ;
Bataille, R .
BLOOD, 2002, 99 (06) :2185-2191
[4]
Avet-Loiseau H, 1999, GENE CHROMOSOME CANC, V24, P9, DOI 10.1002/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO
[5]
2-K
[6]
BAKKUS MHC, 1992, BLOOD, V80, P2326
[7]
Chromosome translocations in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
ONCOGENE, 2001, 20 (40) :5611-5622
[8]
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma [J].
Bergsagel, PL ;
Chesi, M ;
Nardini, E ;
Brents, LA ;
Kirby, SL ;
Kuehl, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13931-13936
[9]
BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190
[10]
Recurrent immunoglubulin gene translocations identify distinct molecular subtypes of myeloma [J].
Chesi, M ;
Kuehl, WM ;
Bergsagel, PL .
ANNALS OF ONCOLOGY, 2000, 11 :131-135